Elfn1 protein has been shown to play a role in the modulation of synaptic transmission through its trans interaction with the metabotropic glutamate receptors69, which serve as therapeutic targets for several neurological diseases, including Alzheimer’s disease, epilepsy, and Parkinson’s disease70–72. This evidence concerns the gene ELFN1 and Alzheimer disease.